Khondrion Receives FDA Clearance for Sonlicromanol Phase 3
14 Nov 2024 //
GLOBENEWSWIRE
Khondrion`s Ph 2b Data on Sonlicromanol in Mitochondrial Disease
07 Nov 2024 //
GLOBENEWSWIRE
Khondrion announces grant of patents in the US and Europe for sonlicromanol
01 Nov 2023 //
PR NEWSWIRE